SOLUBLE COLLAGEN VI FOR USE IN THE TREATMENT OF HYPERGLYCEMIA LINKED DISEASES AND GLUCOSE TRANSPORT DISORDERS. PHARMACEUTICAL COMPOSITION, METHOD AND USE OF A CELL EXTRACELLULAR LIQUID MEDIUM FOR INCREASING GLUCOSE UPTAKE

摘要

Soluble collagen VI for use in the treatment of hyperglycemia linked diseases, wherein said disease is selected from the group composed by diabetes mellitus, metabolic syndrome, dysfunction of the thyroid gland, dysfunction of the adrenal gland, dysfunction of the pituitary gland, exocrine pancreatic diseases, acute stress, sepsis, infection with hepatitis C. The present invention also relates to soluble collagen VI for use in the treatment of glucose transport disorders. The present invention also relates to a pharmaceutical composition comprising soluble collagen VI, to the use of a cell extracellular liquid medium comprising soluble collagen VI for increasing glucose uptake in mammalian cells and to a kit and a method for increasing glucose uptake in mammalian cells.